Andrew N. Stephens (146338)

No ORCID on file · 12 papers in corpus · active 2016-2020

Study types

  • other 7
  • article 3
  • dataset 2

Condition tags

  • endometriosis 3
other 2020
·doi:10.3389/fonc.2020.01767.s001

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

other 2020
·doi:10.3389/fonc.2020.01767.s002

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

other 2020
·doi:10.3389/fonc.2020.01767.s003

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

other 2020
·doi:10.3389/fonc.2020.01767.s004

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

other 2020
·doi:10.3389/fonc.2020.01767.s005

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

other 2020
·doi:10.3389/fonc.2020.01767.s006

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

other 2020
·doi:10.3389/fonc.2020.01767.s007

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

dataset 2020
·doi:10.3389/fonc.2020.01767.s008

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

dataset 2020
·doi:10.3389/fonc.2020.01767.s009

Ovarian cancer is the most lethal gynecologic malignancy. Early detection would improve survival, but an effective diagnostic test does not exist. Novel biomarkers for early ovarian cancer diagnosis are therefore warranted. We performed int…

article 2016
·doi:10.1021/pr901131p.s003

Endometriosis is a chronic disorder affecting ∼10% of women in whom endometrial tissue forms painful lesions outside the uterus. It has a major impact on their physical, mental and social well-being but has no known cure, and there is no no…

article 2016
·doi:10.1021/pr901131p.s002

Endometriosis is a chronic disorder affecting ∼10% of women in whom endometrial tissue forms painful lesions outside the uterus. It has a major impact on their physical, mental and social well-being but has no known cure, and there is no no…

article 2016
·doi:10.1021/pr901131p.s001

Endometriosis is a chronic disorder affecting ∼10% of women in whom endometrial tissue forms painful lesions outside the uterus. It has a major impact on their physical, mental and social well-being but has no known cure, and there is no no…